
Anti-PARP Antibody, Rabbit Polyclonal General Information
Anti-PARP Antibody, Rabbit Polyclonal Validated Applications
Application | Dilution |
---|---|
WB | 1:500-1:2000 |
IHC-P | 1:1000-1:4000 |
ICC-IF | 1:200-1:1000 |
IP | 1-4 μL/mg of lysate |
Anti-PARP Antibody, Rabbit Polyclonal Images
-HD09FE2722-1ug-HeLa-IF.png)
-HD09FE2722-0.5ug-placenta-IHC-P.png)
-HD09FE2722-0.5ug-brain-IHC-P.png)
-HD09FE2722-IP.png)
PARP1 was immunoprecipitated using:
Lane A:0.5 mg Raji Whole Cell Lysate
4 µL anti-PARP1 rabbit polyclonal antibody and 15 μl of50 %Protein G agarose.
Primary antibody:
Anti-PARP1 rabbit polyclonal antibody,at 1:100 dilution
Secondary antibody:
Dylight 800-labeled antibody to rabbit IgG (H+L), at 1:5000 dilution
Developed using the odssey technique.
Performed under reducing conditions.
Predicted band size: 113 kDa
Observed band size: 113 kDa
-HD09FE2722-WB.png)
Anti-PARP1 rabbit polyclonal antibody at 1:500 dilution
Lane A: JurkatWhole Cell Lysate
Lane B: RajiWhole Cell Lysate
Lysates/proteins at 30 μg per lane.
Secondary
Goat Anti-Rabbit IgG H&L (Dylight800)at 1/10000 dilution.
Developed using the Odyssey technique.
Performed under reducing conditions.
Predicted band size:113 kDa
Observed band size:120 kDa
(We are unsure as to the identity of these extra bands.)
Anti-PARP Antibody, Rabbit Polyclonal: Synonyms
PARP Background Information
- Cancer Immunotherapy
- Immune Checkpoint
- Immunotherapy
- Targeted Therapy
- Cancer Drug Targets
- Malanga M. et al., 1998, J Biol Chem. 273: 11839-11843.
- Ariumi Y. et al., 1999, Oncogene. 18: 4616-4625.
- Helleday T. et al., 2005, Cell Cycle. 4: 1176-1178.
- Ahell I. et al., 2008, Nature. 451: 81-85.
- Synergistic suppression effect on tumor growth of acute myeloid leukemia by combining cytarabine with an engineered oncolytic vaccinia virusAuthorPeng, J;Wang, S;Fan, W;Li, S;Wu, Y;Mou, X;Wang, J;Tong, X;Year2018JournalOnco Targets TherApplicationWBPubMed ID: 30410347FoldedExpand
- Enhancing the antitumor activity of an engineered TRAIL-coated oncolytic adenovirus for treating acute myeloid leukemiaAuthorWang, Z;Liu, W;Wang, L;Gao, P;Li, Z;Wu, J;Zhang, H;Wu, H;Kong, W;Yu, B;Yu, X;Year2020JournalSig Transduct Target TherApplicationWBFoldedExpand
If you couldn"t find the specific citation, you can:
- Find All Citations
- Submit a CitationGet a Publication Reward
- Leave Us a Message
Recombinant Antibody Production Service
High-throughput Recombinant Antibody Production
Large-scale Antibody Production
Antibody Development Service
Rabbit MAb Production Service
Mouse MAb Production Service
Rabbit PAb Production Service
Phospho-Specific Antibody
Anti-Idiotype Antibody
Fast Antibody Development Service
Mouse MAb
Rabbit PAb
More Antibody Production Service
Hybridoma Antibody Production
Chimeric Antibody
Antibody Fragment
Bispecific Antibody
We also have Immunoassay Service. Click to see more.